HLA Web Resource for SNPs, Populations, Resources, ADRs, Diseases

Select Categories

Show Entries
Search:
PMID Allele Disease Population Drug Names SNP Class Sentence
17620821 HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) carbamazepine NA allopurinol NA negation
NA
18192896 HLA-B (HLA-B) nevirapine Chinese Han allopurinol NA unclassified
NA
18385790 HLA-CLASS I (HLA CLASS II) stevens-johnson syndrome Japanese NA NA unclassified
hla class i and ii gene polymorphisms in stevens-johnson syndrome with ocular complications in japanese.
18637831 HLA-B*15 phenytoin Chinese Han carbamazepine NA unclassified
NA
18637831 HLA-B*15 phenytoin Chinese Han carbamazepine NA negation
NA
18855540 HLA-B*15 stevens-johnson syndrome Chinese Han carbamazepine NA unclassified
carbamazepine, hla-b*1502 and risk of stevens-johnson syndrome and toxic epidermal necrolysis: us fda recommendations.
18855540 HLA-B*15 stevens-johnson syndrome Chinese Han carbamazepine NA unclassified
owing to recent data implicating the hla allele b*1502 as a marker for carbamazepine-induced stevens-johnson syndrome and toxic epidermal necrolysis in han chinese, the fda recommends genotyping all asians for the allele.
19018717 HLA-B (HLA-B) stevens-johnson syndrome Chinese Han NA NA unclassified
hla-b locus in japanese patients with anti-epileptics and allopurinol-related stevens-johnson syndrome and toxic epidermal necrolysis.
19262378 HLA-B*15 phenytoin Asian carbamazepine NA unclassified
NA
19474732 HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) stevens-johnson syndrome NA infliximab NA unclassified
purpose of reviewthis study summarizes current research and understanding of the pathogenesis of stevens-johnson syndrome (sjs) and toxic epidermal necrolysis (ten) and provides an update on the treatment of these conditions in children.recent findingsthe association of specific human leukocyte antigen subtypes with sjs and ten occurring in certain racial groups to specific drugs has led to recommendations on pretreatment testing.
CSIR logo Trisutra csir_logo

Copyright 2024